IND.241: A Canadian Cancer Trials Group liquid-biopsy informed platform trial to evaluate treatment in CDK4/6-inhibitor resistant ER+/HER2- metastatic breast.

Authors: David W. Cescon, Moira Rushton, Nathalie LeVasseur, Michelle B. Nadler, Daniel Rayson, Brooke Wilson, Sara Kristina Taylor, Rossanna C. Pezo, Arif Ali Ali Awan, Vikaash Kumar, Jen E. Melvin, John Frederick Hilton, Stephen K. L. Chia, Philippe Bedard, Spencer Finn, Wei Tu, Courtney Coschi, Philippe Jamme, Elia Aguado-Fraile, Lesley K. Seymour

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps1121

Source: Full article

---

Abstract

TPS1121